IBB US · ETF FactsheetiShares Biotechnology ETF
Generated by Nukoud (nukoud.com) for informational purposes only — not investment advice, a recommendation, or an offer to buy or sell any security. Data is sourced from third-party providers and may be delayed or inaccurate. Past performance is not indicative of future results.
iShares Biotechnology ETF
Exchange-Traded FundTechnical indicators
End of dayMoving averages
- 20-day SMA
- 211.98 USD+2.46%Bullish
- 50-day SMA
- 208.85 USD+3.99%Bullish
- 100-day SMA
- 202.58 USD+7.21%Bullish
- 200-day SMA
- 186.46 USD+16.48%Bullish
- 12-day EMA
- 214.72 USD+1.14%Bullish
- 26-day EMA
- 211.96 USD+2.46%Bullish
Oscillators
Sign in for the oscillators
RSI, MACD, Bollinger position and volatility for this fund — plus signal changes across every listing Nukoud tracks. A free account covers it.
Checking your session…Range & bands
Calculated from end-of-day closing prices. They describe how this fund has already traded, not what it will do next, and are information only — not advice.
About this fund
iShares Biotechnology ETF (IBB) is a Health ETF managed by BlackRock Fund Advisors, listed on Nasdaq - All Markets, quoted in USD. It charges a 0.44% net expense ratio and holds $11.34B in assets as of Nov 10, 2026. The fund launched on Feb 5, 2001.
- Benchmark
- NYSE BiotechnologyTotal return, USD
- Distribution
- Quarterly
- AUM
- $11.34B
- Expense Ratio
- 0.44%
- Yield (12-mo)
- -0.15%
- Morningstar Rating
- Benchmark
- NYSE Biotechnology
- 52-Week Range
- Avg Daily Vol
- 1.72M
- Inception
- Feb 5, 2001
Risk metrics
vs benchmark NYSE Biotechnology · Total return, USD
3-year risk statistics are not currently available for this fund.
Risk statistics are 3-year, month-end-based.
Trailing returns
As of Nov 10, 2026Calendar-year returns
Morningstar daily closesTrading & liquidity
as of Nov 10, 2026
Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.
Top 10 holdings
Source: MorningstarFees & expenses
Distributions
12-month yield
Recent payments per share (USD)
Classification
- Category
- Equity – Sector
- Asset class
- Equity
- Strategy
- Passive
- Themes
- Biotechnology
- Sector
- Health Care
- Region
- US
- Issuer
- BlackRock Fund Advisors
- Branding
- iShares
Similar ETFs
Funds sharing the same category or exposures.
- XLVUS$50.35B0.080%+23.52%
State Street® Health Care Select Sector SPDR® ETF
Same category · Same sector · Same region
- GNOMUS$105.76M0.500%+43.65%
Global X Genomics & Biotechnology ETF
Same category · Same sector · biotechnology
- VGTUS$167.05B0.090%+17.70%
Vanguard Information Technology Index Fund
Same group · Same region
- XLKUS$114.21B0.080%+17.74%
State Street® Technology Select Sector SPDR® ETF
Same group · Same region
- XLFUS$54.05B0.080%+7.72%
State Street® Financial Select Sector SPDR® ETF
Same group · Same region
- XLEUS$40.93B0.080%+41.90%
State Street® Energy Select Sector SPDR® ETF
Same group · Same region
Frequently asked questions
- What is IBB's expense ratio?
- iShares Biotechnology ETF charges a net expense ratio of 0.440%.
- How large is iShares Biotechnology ETF?
- IBB holds $11.34B in assets under management.
- What index does IBB track?
- iShares Biotechnology ETF tracks NYSE Biotechnology as its primary benchmark.
- When did IBB launch?
- iShares Biotechnology ETF launched on February 5, 2001.
- What currency does IBB trade in?
- IBB trades in USD on Nasdaq - All Markets.
Fund information
- Ticker
- IBB
- Performance ID
- 0P00002DAH
- Inception
- Feb 5, 2001
- Domicile
- USA
- Base currency
- USD
- Listing currency
- USD
- AUM
- $11.34B
- Avg daily volume (3M)
- 1.72M
Charting by TradingView.
